Cachexia: A systemic consequence of progressive, unresolved disease M Ferrer, TG Anthony, JS Ayres, G Biffi, JC Brown, BJ Caan, ... Cell 186 (9), 1824-1845, 2023 | 89 | 2023 |
Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia M Ferrer, N Mourikis, EE Davidson, SO Kleeman, M Zaccaria, J Habel, ... Cell metabolism 35 (7), 1147-1162. e7, 2023 | 52 | 2023 |
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial CM Brennan, S Nadella, X Zhao, RJ Dima, N Jordan-Martin, ... Gut 71 (5), 879-888, 2022 | 48 | 2022 |
A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy TR Flint, JO Jones, M Ferrer, F Colucci, T Janowitz Seminars in Oncology 45 (3), 170-175, 2018 | 21 | 2018 |
Area postrema neurons mediate interleukin-6 function in cancer cachexia Q Sun, D van de Lisdonk, M Ferrer, B Gegenhuber, M Wu, Y Park, ... Nature Communications 15 (1), 4682, 2024 | 18 | 2024 |
Cystatin C is glucocorticoid-responsive, directs recruitment of Trem2+ macrophages and predicts failure of cancer immunotherapy SO Kleeman, B Demestichas, N Mourikis, D Loiero, M Ferrer, S Bankier, ... Cell Genomics, 2021.08. 17.21261668, 2023 | 16* | 2023 |
Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia M Petruzzelli, M Ferrer, MJ Schuijs, SO Kleeman, N Mourikis, Z Hall, ... Cancers 14 (4), 963, 2022 | 15 | 2022 |
Tumor cytokine-induced hepatic gluconeogenesis contributes to cancer cachexia: insights from full body single nuclei sequencing Y Liu, E Dantas, M Ferrer, Y Liu, A Comjean, EE Davidson, Y Hu, ... bioRxiv, 2023 | 9 | 2023 |
Training the host organism to enhance anti-cancer immunity M Ferrer, T Janowitz Cancer Cell 40 (7), 703-705, 2022 | 2 | 2022 |
A KETOGENIC DIET INDUCES TUMOR FERROPTOSIS BUT ACCELERATES CACHEXIA M Ferrer, N Mourikis, D Ee, K So, M Zaccaria, J Habel CANCER DISCOVERY 13 (8), 1758-1758, 2023 | | 2023 |
Abstract 2891: Cystatin C is glucocorticoid-responsive, directs recruitment of Trem2+ macrophages and predicts failure of cancer immunotherapy SO Kleeman, B Demestichas, N Mourikis, M Ferrer, Q Gao, D Loiero, ... Cancer Research 83 (7_Supplement), 2891-2891, 2023 | | 2023 |
Abstract 1162: Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia M Ferrer, N Mourikis, EE Davidson, SO Kleeman, M Zaccaria, J Habel, ... Cancer Research 83 (7_Supplement), 1162-1162, 2023 | | 2023 |
The host response to cancer and cancer-associated cachexia M Ferrer Gonzalez | | 2023 |
Area postrema neurons mediate interleukin-6 function in cancer-associated cachexia Q Sun, D van de Lisdonk, M Ferrer, B Gegenhuber, M Wu, J Tollkuhn, ... bioRxiv, 2023.01. 12.523716, 2023 | | 2023 |
PO-425 Combined administration of anti-IL6 and anti-PD-L1 antibodies prevents ketogenic failure, reduces tumour progression, and increases overall survival in an autochthonous … M Ferrer, CM Connell, TR Flint, D Biasci, DT Fearon, DI Jodrell, ... ESMO Open 3, A397, 2018 | | 2018 |